Observational studySubstance abuse treatment, prevention, and policy2021
Three-month outcomes from a patient-centered program to treat opioid use disorder in Iowa, USA.
Observational study in Substance abuse treatment, prevention, and policy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Substance Use Disorder Treatment Outcomes: Methodological Overview of Metrics and Criteria.International journal of methods in psychiatric research · 2025Pooled it
- Stakeholder-informed recommendations for patient-centered medication service delivery for stimulant use disorder: a qualitative study.Addiction science & clinical practice · 2026Article
- Brief Addiction Monitor-Taiwan version as a simple tool for the measurement-based care of people who use drugs in the era of harm reduction: predictive validity in prospective follow-ups of patients nationwide.Substance abuse treatment, prevention, and policy · 2026Article
- Longitudinal trajectories in recovery capital and associations with substance use among adult drug treatment court clients.Drug and alcohol dependence · 2024Article
- A qualitative study of a recovery capital assessment tool in alcohol and drug treatment facilities: Perspectives from social work professionals.Nordisk alkohol- & narkotikatidskrift : NAT · 2024Article
- Recovery Capital Gains May Precede Craving Reduction in Opioid Use Disorder.Substance abuse and rehabilitation · 2023Article
- Retention in treatment and therapeutic adherence: How are these associated with therapeutic success? An analysis using real-world data.International journal of methods in psychiatric research · 2022Observational
- Patient evaluation of a smartphone application for telehealth care of opioid use disorder.Addiction science & clinical practice · 2022Article
- The growth of recovery capital in clients of recovery residences in Florida, USA: a quantitative pilot study of changes in REC-CAP profile scores.Substance abuse treatment, prevention, and policy · 2022Article
- Outcomes from the medication assisted treatment pilot program for adults with opioid use disorders in rural Colorado.Substance abuse treatment, prevention, and policy · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundOpioid use disorder (OUD), a chronic disease, is a major public health problem. Despite availability of effective treatment, too few people receive it and treatment retention is low. Understanding barriers and facilitators of treatment access and retention is needed to improve outcomes for people with OUD.
objectivesTo assess 3-month outcomes pilot data from a patient-centered OUD treatment program in Iowa, USA, that utilized flexible treatment requirements and prioritized engagement over compliance.
methodsForty patients (62.5% female: mean age was 35.7 years, SD 9.5) receiving medication, either buprenorphine or naltrexone, to treat OUD were enrolled in an observational study. Patients could select or decline case management, counseling, and peer recovery groups. Substance use, risk and protective factors, and recovery capital were measured at intake and 3 months.
resultsMost participants reported increased recovery capital. The median Assessment of Recovery Capital (ARC) score went from 37 at enrollment to 43 (p < 0.01). Illegal drug use decreased, with the median days using illegal drugs in the past month dropping from 10 to 0 (p < 0.001). Cravings improved: 29.2% reported no cravings at intake and 58.3% reported no cravings at 3 months (p < 0.001). Retention rate was 92.5% at 3 months. Retention rate for participants who were not on probation/parole was higher (96.9%) than for those on probation/parole (62.5%, p = 0.021).
conclusionThis study shows preliminary evidence that a care model based on easy and flexible access and strategies to improve treatment retention improves recovery capital, reduces illegal drug use and cravings, and retains people in treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.